[go: up one dir, main page]

WO2007069264A3 - Reference standards for determining the purity of telithromycin and processes therefor - Google Patents

Reference standards for determining the purity of telithromycin and processes therefor Download PDF

Info

Publication number
WO2007069264A3
WO2007069264A3 PCT/IN2006/000356 IN2006000356W WO2007069264A3 WO 2007069264 A3 WO2007069264 A3 WO 2007069264A3 IN 2006000356 W IN2006000356 W IN 2006000356W WO 2007069264 A3 WO2007069264 A3 WO 2007069264A3
Authority
WO
WIPO (PCT)
Prior art keywords
telithromycin
purity
compound
determining
reference standards
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000356
Other languages
French (fr)
Other versions
WO2007069264A2 (en
Inventor
Pandurang Balwant Deshpande
Parven Kumar Luthra
Rajesh Nautiyal
Bhushan Sahasrabuddhey
Manish Kanchanbhai Patel
Mahesh Pravinchandra Davadra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alembic Ltd
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of WO2007069264A2 publication Critical patent/WO2007069264A2/en
Publication of WO2007069264A3 publication Critical patent/WO2007069264A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A method of testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin, which method comprises assaying the said sample for the presence of compound A, B and D, wherein compound A is represented by following structural formula (I); Compound A compound B is represented by following structural formula (II); and compound B and compound D is represented by following structural formula (III) and the compounds A, B and D as well as their uses as reference markers for testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin.
PCT/IN2006/000356 2005-12-15 2006-09-11 Reference standards for determining the purity of telithromycin and processes therefor Ceased WO2007069264A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1576/MUM/2005 2005-12-15
IN1576MU2005 2005-12-15

Publications (2)

Publication Number Publication Date
WO2007069264A2 WO2007069264A2 (en) 2007-06-21
WO2007069264A3 true WO2007069264A3 (en) 2007-11-29

Family

ID=38163334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000356 Ceased WO2007069264A2 (en) 2005-12-15 2006-09-11 Reference standards for determining the purity of telithromycin and processes therefor

Country Status (1)

Country Link
WO (1) WO2007069264A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009152A1 (en) * 2007-07-12 2009-01-15 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997031929A1 (en) * 1996-02-28 1997-09-04 Hoechst Marion Roussel Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
EP1170588A1 (en) * 1998-06-10 2002-01-09 The Wellcome Foundation Limited A method of testing the purity or stability of 'lamotrigine' with the use of a 1,2,4-triazine derivative as reference marker
WO2002054062A2 (en) * 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
WO2005105821A2 (en) * 2004-04-28 2005-11-10 Alembic Limited Process for the preparation of telithromycin
WO2005108984A2 (en) * 2004-05-06 2005-11-17 Chiron Corporation Methods and systems for detection, identification and quantitation of macrolides and their impurities

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997031929A1 (en) * 1996-02-28 1997-09-04 Hoechst Marion Roussel Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
EP1170588A1 (en) * 1998-06-10 2002-01-09 The Wellcome Foundation Limited A method of testing the purity or stability of 'lamotrigine' with the use of a 1,2,4-triazine derivative as reference marker
WO2002054062A2 (en) * 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
WO2005105821A2 (en) * 2004-04-28 2005-11-10 Alembic Limited Process for the preparation of telithromycin
WO2005108984A2 (en) * 2004-05-06 2005-11-17 Chiron Corporation Methods and systems for detection, identification and quantitation of macrolides and their impurities

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KANFER I ET AL: "Analysis of macrolide antibiotics", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 812, no. 1-2, 3 July 1998 (1998-07-03), pages 255 - 286, XP004127049, ISSN: 0021-9673 *

Also Published As

Publication number Publication date
WO2007069264A2 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
WO2007067923A3 (en) Compositions and methods for detecting phosphomonoester
WO2007120699A3 (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
EP2385053A3 (en) Intermediates for the preparation of fused bicyclic mTOR inhibitors
WO2006133147A3 (en) Organic compounds
WO2009146218A8 (en) Compounds including an anti-inflammatory pharmacore and methods of use
WO2005074642A3 (en) Chemical compounds
WO2007085895A3 (en) Fap inhibitors
WO2008079814A3 (en) Mapk/erk kinase inhibitors
WO2008126374A1 (en) Agent for improving alkali resistance of plant and method for improving alkali resistance of plant
WO2009133556A3 (en) Cisatracurium derivatives, preparation and uses thereof
ZA200804171B (en) Chemical process for the preparation of an amidophenoxybenzoic acid compound
GB0521508D0 (en) Organic compounds
WO2008051826A3 (en) Purines as pkc-theta inhibitors
WO2008054956A3 (en) Kinase inhibitors
WO2009066735A1 (en) Method for producing 2-azaadamantane
WO2006087143A8 (en) Novel processes for the preparation of a 2h-chromene
WO2008102469A1 (en) Protein crystallizing agent and method of crystallizing protein therewith
WO2008103367A3 (en) Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
WO2007069264A3 (en) Reference standards for determining the purity of telithromycin and processes therefor
WO2005080403A3 (en) Chemical process
NO20072551L (en) Process for the preparation of purine compounds
GT200600026A (en) METHOD FOR ANALYZING THE PHOSPHOROUS ACID, THE FOSETIL-AL OR BOTH SIMULTANEOUSLY
WO2007085651A8 (en) Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
WO2005074389A1 (en) Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06842745

Country of ref document: EP

Kind code of ref document: A2